Multivalent influenza vaccine using exosomes from probiotic E. Coli
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43IP001127
- Recipient
-
Versatope Therapeutics Inc. UEI VSMPM3EGYYA6
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $45,808
Award facts
- Assistance listing
- 93.061 Innovations in Applied Public Health Research
- Completion date
- Funding agency
- National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- Lowell, MA, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$2 | |
| Amendment | -$2 | |
| Amendment | $31,910 | |
| Amendment | $31,910 | |
| Amendment | -$121,504 | |
| Amendment | -$121,504 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R43IP001127?
R43IP001127 was awarded to Versatope Therapeutics Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 1, 2019.
How much is award R43IP001127 worth?
$45,808 has been obligated on R43IP001127.
Which agency awarded R43IP001127?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001127, with funding from National Center for Immunization and Respiratory Diseases (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award